Cardiff Oncology (CRDF) Preferred Dividend Payments (2011 - 2026)

Cardiff Oncology has reported Preferred Dividend Payments for 15 years, with the latest figure at $7000.0 in Q4 2025.

• Quarterly Preferred Dividend Payments rose 16.67% year-over-year to $7000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25000.0 (up 4.17% YoY) and the FY2025 annual result came in at $25000.0, up 4.17% from the prior year.
• Preferred Dividend Payments climbed to $7000.0 in Q4 2025 per CRDF's latest filing, from $6000.0 in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at $7000.0 in Q4 2025 and troughed at $6000.0 in Q1 2021.
• A 5-year average of $6050.0 and a median of $6000.0 in 2021 frame the typical range for Preferred Dividend Payments.
• The sharpest annual moves came in 2021 and 2025: Preferred Dividend Payments changed 0.0% in 2021, then rose 16.67% in 2025.
• Over 5 years, Preferred Dividend Payments stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then rose by 16.67% to $7000.0 in 2025.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered $7000.0, $6000.0, and $6000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.